Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of β-catenin
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Androgens promote anabolism in the musculoskeletal system while generally repressing adiposity, leading to lean body composition. Circulating androgens decline with age, contributing to frailty, osteoporosis, and obesity; however, the mechanisms by which androgens modulate body composition are largely unknown. Here, we demonstrate that aged castrated rats develop increased fat mass, reduced muscle mass and strength, and lower bone mass. Treatment with testosterone or 5α-dihydrotestosterone (DHT) reverses the effects on muscle and adipose tissues while only aromatizable testosterone increased bone mass. During the first week, DHT transiently increased soleus muscle nuclear density and induced expression of IGF1 and its splice variant mechano growth factor (MGF) without early regulation of the myogenic factors MyoD, myogenin, monocyte nuclear factor, or myostatin. A genome-wide microarray screen was also performed to identify potential pro-myogenic genes that respond to androgen receptor activation in vivo within 24 h. Of 24 000 genes examined, 70 candidate genes were identified whose functions suggest initiation of remodeling and regeneration, including the type II muscle genes for myosin heavy chain type II and parvalbumin and the chemokine monocyte chemoattractant protein-1. Interestingly, Axin and Axin2, negative regulators of β-catenin, were repressed, indicating modulation of the β-catenin pathway. DHT increased total levels of β-catenin protein, which accumulated in nuclei in vivo. Likewise, treatment of C2C12 myoblasts with both IGF1Ea and MGF C-terminal peptide increased nuclear β-catenin in vitro. Thus, we propose that androgenic anabolism involves early downregulation of Axin and induction of IGF1, leading to nuclear accumulation of β-catenin, a pro-myogenic, anti-adipogenic stem cell regulatory factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575 · cited 2×
“Since muscle matrix undergoes significant changes during embryogenesis (Visse and Nagase 2003) and regeneration (Charge and Rudnicki 2004), this gene could function in that process.”
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“Moreover, b-catenin is essential for adult skeletal muscle growth and regeneration in vivo (Polesskaya et al. 2003, Reya & Clevers 2005, Armstrong et al. 2006), and myonuclear b-catenin is up-regulated during overload-induced muscle hypertrophy in adults (Armstrong & Esser 2005).”
BackgroundHolmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Musarò, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., L Sweeney, H., & Rosenthal, N. (2001) · Nature Genetics · doi:10.1038/84839 · Cited by 1,137 · cited 1×
“As IGF1 and its related splice variants stimulate satellite cell proliferation and promote muscle hypertrophy (Musaro et al. 2001, Hill & Goldspink 2003, Goldspink & Yang 2004), these data suggest that androgens regulate muscle mass by this mechanism.”
BackgroundSteroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105 · cited 1×
“Testosterone, the major circulating androgen, can act directly or be converted to the more potent androgen 5a-dihydrotestosterone (DHT) by 5a-reductase, or to estrogens by aromatase (Russell & Wilson 1994, Simpson et al. 1994).”
BackgroundMyostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014 · cited 2×
“myostatin (Thomas et al. 2000) and TGF-b (Massague et al.”
BackgroundLamberts, S. W. J., van den Beld, A. W., & van der Lely, A.-J. (1997) · Science · doi:10.1126/science.278.5337.419 · Cited by 980
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943 · cited 2×
“Both testosterone and DHT activate the androgen receptor (AR), a nuclear receptor that functions as a transcription factor in hormone-sensitive cells (Chang et al. 1995, Heinlein & Chang 2002).”
BackgroundKatznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954042 · Cited by 791 · cited 3×
“Treatment with testosterone improves muscle mass and strength, bone density, and reduces visceral fat in a variety of subjects (Bardin 1996, Katznelson et al. 1996, Bhasin et al. 1997, 2000, Swerdloff & Wang 2003).”
BackgroundSingh, R., Artaza, J. N., Taylor, W. E., Gonzalez-Cadavid, N. F., & Bhasin, S. (2003) · Endocrinology · doi:10.1210/en.2003-0741 · Cited by 555
Effect of Testosterone Treatment on Body Composition and Muscle Strength in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2647 · Cited by 531 · cited 2×
“0952–5041/10/044–055 q 2010 Society for Endocrinology Printed in Great Britain This loss of endogenous androgens parallels several symptoms of aging, including decreased muscle mass and function (Snyder et al. 1999), increased visceral fat (Katznelson et al.”
BackgroundFerrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522 · cited 2×
“Other studies report changes in the local expression of insulin-like growth factor 1 (IGF1) in muscle samples from patients receiving anabolic androgens (Sheffield-Moore 2000, Ferrando et al. 2002).”
BackgroundTestosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men1
Bhasin, S., Storer, T. W., Berman, N., Yarasheski, K. E., Clevenger, B., Phillips, J., Lee, W. P., Bunnell, T. J., & Casaburi, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3733 · Cited by 522
Sinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A. B., Lee, M. I., Storer, T. W., Casaburi, R., Shen, R., & Bhasin, S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00502.2001 · Cited by 464
Sinha-Hikim, I., Roth, S. M., Lee, M. I., & Bhasin, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00370.2002 · Cited by 344 · cited 1×
“Furthermore, in muscle biopsies from men that exhibited gains in myofiber volume and strength following 20 weeks of testosterone treatment, satellite cell number was increased (Sinha-Hikim et al. 2003).”
BackgroundInfluentialLinking β-Catenin to Androgen-signaling Pathway
Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111962200 · Cited by 342 · cited 1×
“Interestingly, b-catenin and AR physically and functionally interact in prostate and neuronal cells (Pawlowski et al. 2002, Yang et al. 2002), suggesting crosstalk between androgen and Wnt signaling.”
BackgroundBhasin, S., Taylor, W. E., Singh, R., Artaza, J., Sinha-Hikim, I., Jasuja, R., Choi, H., & Gonzalez-Cadavid, N. F. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.12.m1103 · Cited by 215 · cited 1×
“Histological examination of androgen-treated soleus Several reports suggest that androgens modulate the number of myogenic precursors and affect fiber number and/or diameter (Bhasin et al. 1997, 2003, Sinha-Hikim et al. 2002).”
BackgroundMacLean, H. E., Chiu, W. S. M., Notini, A. J., Axell, A.-M., Davey, R. A., McManus, J. F., Ma, C., Plant, D. R., Lynch, G. S., & Zajac, J. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-105726 · Cited by 209
Liganded Androgen Receptor Interaction with β-Catenin
Pawlowski, J. E., Ertel, J. R., Allen, M. P., Xu, M., Butler, C., Wilson, E. M., & Wierman, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200545200 · Cited by 166 · cited 1×
“Interestingly, b-catenin and AR physically and functionally interact in prostate and neuronal cells (Pawlowski et al. 2002, Yang et al. 2002), suggesting crosstalk between androgen and Wnt signaling.”
BackgroundAndrogen regulation of satellite cell function
Chen, Y., Zajac, J. D., & MacLean, H. E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05976 · Cited by 137 · cited 2×
“At the cellular level, the effects of testosterone on body composition might involve recruitment or activation of resident myogenic precursor cells to existing myofibers (Chen et al. 2005b).”
BackgroundVandenput, L., Boonen, S., Van Herck, E., Swinnen, J. V., Bouillon, R., & Vanderschueren, D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.11.2080 · Cited by 100 · cited 1×
“Since many studies use testosterone, the relative contributions of the AR and estrogen receptors are ambiguous, and some report that estrogen is an essential component of androgenic anabolism (Bilezikian et al. 1998, Vandenput et al. 2002).”
BackgroundVanderschueren, D., Vandenput, L., Boonen, S., Van Herck, E., Swinnen, J. V., & Bouillon, R. (2000) · Endocrinology · doi:10.1210/endo.141.5.7472 · Cited by 88
Cited by
Kunkel, S. D., Suneja, M., Ebert, S. M., Bongers, K. S., Fox, D. K., Malmberg, S. E., Alipour, F., Shields, R. K., & Adams, C. M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.020 · Cited by 345
“IGF1 mRNA is known to be transcriptionally induced in hypertrophic muscle (Adams and Haddad, 1996; Gentile et al., 2010; Hameed et al., 2004).”
Mauvais-Jarvis, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.10.002 · Cited by 335
The role of androgens in metabolism, obesity, and diabetes in males and females
Navarro, G., Allard, C., Xu, W., & Mauvais‐Jarvis, F. (2015) · Obesity · doi:10.1002/oby.21033 · Cited by 289
Myostatin decreases with aerobic exercise and associates with insulin resistance
HITTEL, D. S., AXELSON, M., SARNA, N., SHEARER, J., HUFFMAN, K. M., & KRAUS, W. E. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0b9a8 · Cited by 271
Mavalli, M. D., DiGirolamo, D. J., Fan, Y., Riddle, R. C., Campbell, K. S., van Groen, T., Frank, S. J., Sperling, M. A., Esser, K. A., Bamman, M. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42447 · Cited by 213
Metadata
- Authors
- Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P., Cheng, C., Dai, H., Freedman, L. P., & Ray, W. J.
- Venue
- Journal of Molecular Endocrinology
- Publisher
- Bioscientifica
- Published
- 2009-09-01
- Volume
- 44
- Issue
- 1
- Pages
- 55-73
- ISSN
- 0952-5041 (ISSN-L)
- 1479-6813
- OpenAlex
- W2118332964
- Cited by
- 75
- References
- 23
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.